Vanda Pharmaceuticals, Inc. (VNDA)
7.47
+0.02
(+0.27%)
USD |
NASDAQ |
Jan 16, 16:00
7.50
+0.03
(+0.40%)
After-Hours: 20:00
Vanda Pharmaceuticals Market Cap: 441.45M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aldeyra Therapeutics, Inc. | 278.55M |
| Eli Lilly & Co. | 929.39B |
| ADMA Biologics, Inc. | 4.120B |
| Axsome Therapeutics, Inc. | 8.937B |
| AnaptysBio, Inc. | 1.265B |
Market Cap Related Metrics
| PS Ratio | 2.069 |
| PEG Ratio | -0.0128 |
| Price to Book Value | 0.9473 |
| Price | 7.47 |
| Earnings Yield | -19.16% |
| PEGY Ratio | -0.0128 |